Pain Management

Pharmacogenomic testing can help identify patients' genetic profiles, revealing why certain drugs may be less effective or cause adverse effects.

The updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.

In previous studies, semaglutide was found to modulate dopamine reward signaling and decreased drug rewards (specifically heroin) in rodents.

Pharmacists have developed an expanded role in the team-based approach through medication therapy management.

The weight loss drug continues to show promise in treating a variety of other conditions.

The guidelines mark a shift in practice by recommending a multimodal approach to opioid prescribing practices.

The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.

The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.

Pharmacists should educate patients about proper medication storage and offer naloxone to optimize safety.

AI and other technologies, in conjunction with ASHP’s guidelines, can improve drug diversion monitoring and outcomes.

Setting realistic goals can improve patients’ medication adherence and self-efficacy.

The injection adds an additional option to address emergency known or suspected opioid overdoses.

If approved, the drug would be the first in a new class of medications to treat acute pain in over 20 years.

The authors note they will continue to investigate treatments for patients with lupus as well as safe and effective methods of delivering these molecules to patients.

Pharmacists can prevent medication errors through knowledge, communication, and education

Allison Burns discusses how pharmacists should prepare and educate themselves regarding OTC naloxone, and the steps that can be taken in stores and pharmacies to ensure OTC naloxone is visible and available.

Allison Burns, president and CEO of EMO Health, discusses the price point and stigma surrounding OTC naloxone in an interview with Pharmacy Times.

Results show that daily injections of buprenorphine over a 7-day period was safe and well-tolerated in patients who had Clinical Opioid Withdrawal Scale scores of 4 to 7.

In pediatric and adult patients, the top 3 surgical procedures accounted for the highest share of opioid prescriptions, indicating a need for better opioid prescription management and greater awareness of the possible opioid-related adverse events that can stem from prescriptions of the drug.

Roughly one-third of patients with cancer do not achieve adequate pain control.

Early diagnosis and comprehensive treatment may lead to full recovery for patients.

Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.

Expert discusses the challenges faced by pharmacists in palliative and hospice care.

Pharmacists play a crucial role in managing pain for cancer patients in palliative care.